Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01413061 · ClinicalTrials.gov registry record · NA
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
A NA study, sponsored by AlloSource.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT01413061 is a NA study that has completed, run by AlloSource. The registered enrollment target is 140 participants.
The verdict
NCT01413061, a NA study, has completed, sponsored by AlloSource.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the outcome of implanting AlloStem® graft with appropriate rigid internal fixation hardware as an alternative to autograft bone graft with rigid fixation in subtalar arthrodesis procedures. The primary objective of this clinical trial is to compare the overall fusion rate of the investigational to the control treatment. Fusion will be determined by clinical findings, radiographs and computed tomography (CT) of the subtalar joint 24 weeks (6 months) after the trial surgery.
Interventions
- PROCEDURE Subtalar Arthrodesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2010-06 |
| Est. Completion | 2018-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01413061
The ClinicalTrials.gov registry entry for NCT01413061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AlloSource, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Subtalar Arthrodesis is the first listed.
NCT01413061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01413061 about?
NCT01413061 is a clinical study titled "Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft". The purpose of this clinical trial is to evaluate the outcome of implanting AlloStem® graft with appropriate rigid internal fixation hardware as an alternative to autograft bone graft with rigid fixation in subtalar arthrodesis procedures. The primary objective of this clinical trial is to compare t...
What is the current status of trial NCT01413061?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2010-06. Estimated completion is 2018-03.
What interventions are being tested in trial NCT01413061?
The interventions under investigation include: Subtalar Arthrodesis (PROCEDURE).
Who is sponsoring clinical trial NCT01413061?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.